Skip to main content

Table 3 MENQOL scores based on the four domains among studied patients

From: Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors

 vasomotor domainpsychosocial domainphysical domainsexual domain
Mean scoreSDpMean scoreSDpMean scoreSDpMean scoreSDp
Overall population2.511.702.761.412.821.102.611.90
No. of patients with scores >/= mean (%)103 (36.8)  119 (42.5)  130 (46.4)  107 (38.2)  
Age at time of study entry  0.1227  0.1036  0.6317  0.2397
  ≤ 402.251.69 2.281.13 2.731.14 1.991.53 
 41–452.461.73 2.931.51 2.951.20 2.651.84 
 46–502.701.75 2.811.41 2.781.03 2.702.02 
  > 501.901.01 2.481.34 2.741.13 2.811.70 
BMI at study entry  0.8753  0.3717  0.0162  0.2760
 Underweight or Normal2.531.73 2.681.37 2.651.07 2.741.93 
 Overweight or Obese2.501.67 2.831.44 2.971.11 2.491.87 
Breast surgery:  0.9321  0.6877  0.5563  0.1375
 Lumpectomy2.521.69 2.711.42 2.761.05 2.371.64 
 Mastectomy2.501.70 2.781.41 2.841.13 2.732.01 
Axillary nodal dissection  0.6127  0.3630  0.7797  0.1500
 Yes2.521.70 2.751.41 2.811.10 2.631.90 
 No2.081.95 3.390.88 2.970.61 1.250.50 
Adjuvant radiotherapy  0.7467  0.3781  0.7246  0.9861
 Yes2.531.58 2.701.36 2.831.05 2.611.87 
 No2.461.76 2.861.50 2.781.18 2.610.50 
Adjuvant chemotherapy regimen:  0.0140  0.9373  0.7131  0.9094
 Taxane-containing2.911.89 2.751.26 2.851.02 2.591.84 
 Non-taxane-containing2.351.59 2.761.46 2.801.13 2.621.92 
Duration of adjuvant chemotherapy  0.2232  0.3966  0.8625  0.8946
  < =64 days2.331.75 2.861.51 2.801.14 2.632.09 
  > 64 days2.601.57 2.711.36 2.821.08 2.601.80 
Time since last adjuvant treatment*  0.2568  0.4249  0.3966  0.3051
 3 to < 5 years2.611.69 2.701.36 2.771.08 2.511.85 
 5 to < 10 years2.381.70 2.831.47 2.881.13 2.741.96 
Ever received adjuvant tamoxifen  0.8659  0.8076  0.8320  0.7338
 Yes2.521.76 2.771.38 2.821.12 2.591.88 
 No2.481.50 2.721.52 2.791.03 2.681.98 
On adjuvant tamoxifen at study entry  0.0479  0.7057  0.9349  0.6175
 Yes2.751.84 2.791.32 2.821.10 2.541.86 
 No2.341.57 2.731.47 2.811.10 2.651.93 
Adjuvant targeted therapy with trastuzumab  0.7117  0.8083  0.9443  0.7262
 Yes2.291.20 2.881.56 2.790.72 2.381.86 
 No2.521.71 2.751.41 2.821.11 2.611.90 
Utilization of traditional Chinese medicine since diagnosis  0.0054  0.0028  0.0052  0.3732
 Yes2.941.80 3.141.55 3.101.19 2.761.95 
 No2.331.62 2.591.31 2.701.04 2.541.88 
Menopausal status at study entry  0.2079  0.7446  0.9338  0.0229
 Premenopausal2.351.67 2.721.49 2.821.16 2.291.64 
 Peri/Post- menopausal2.621.71 2.781.35 2.811.06 2.822.03 
  1. *Only include chemotherapy/radiotherapy or trastuzumab